CD16 Activators

Common CD16 Activators include, but are not limited to GM-CSF CAS 83869-56-1, PMA CAS 16561-29-8, Retinoic Acid, all trans CAS 302-79-4, Cholecalciferol CAS 67-97-0 and Zymosan CAS 9010-72-4.

CD16 activators are compounds or agents that interact with and modulate the CD16 antigen, also known as FcγRIII (Fc gamma receptor III). CD16 is a cell surface receptor primarily found on immune cells, particularly natural killer (NK) cells, monocytes, macrophages, and neutrophils. It plays a crucial role in mediating immune responses, especially those involving antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis. CD16 exists in two main isoforms, CD16A (FcγRIIIA) and CD16B (FcγRIIIB), which differ in their cellular distribution and function.

CD16A is mainly expressed on NK cells, monocytes, and macrophages. It binds to the Fc region of immunoglobulin G (IgG) antibodies, allowing immune cells to recognize and eliminate antibody-coated pathogens or infected cells. This interaction triggers various immune effector functions, such as the release of cytotoxic granules, pro-inflammatory cytokines, and the engulfment of target cells. On the other hand, CD16B is primarily expressed on neutrophils and is involved in immune responses to pathogens, but its exact role is still being elucidated. CD16 activators, in the context of research and immunology, refer to agents or compounds that can influence the activity or expression of CD16 on immune cells. By modulating CD16 function, these activators have the potential to impact immune responses and the elimination of target cells through ADCC and phagocytosis, contributing to our knowledge of immune regulation and host defense mechanisms.